These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35934900)

  • 1. Temporally specific adrenocorticotropic hormone reference intervals for horses in South Africa.
    Fisher D; Schliewert EC; Hooijberg EH
    J S Afr Vet Assoc; 2022 Nov; 93(2):116-123. PubMed ID: 35934900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.
    Menzies-Gow NJ; Banse HE; Duff A; Hart N; Ireland JL; Knowles EJ; McFarlane D; Rendle D
    Equine Vet J; 2024 Mar; 56(2):220-242. PubMed ID: 37795557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
    Copas VE; Durham AE
    Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses.
    Horn R; Stewart AJ; Jackson KV; Dryburgh EL; Medina-Torres CE; Bertin FR
    J Vet Intern Med; 2021 Jan; 35(1):560-570. PubMed ID: 33368633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of seasonal influences on adrenocorticotropic hormone response to the thyrotropin-releasing hormone stimulation test and its accuracy for diagnosis of pituitary pars intermedia dysfunction.
    Adams AA; Siard-Altman MH; Reedy SE; Barker D; Elzinga S; Sanz MG; Urschel K; Ireland JL
    Vet J; 2023; 300-302():106035. PubMed ID: 37802466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction.
    Rendle DI; Litchfield E; Heller J; Hughes KJ
    Equine Vet J; 2014 Jan; 46(1):113-7. PubMed ID: 23742059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses.
    Hu K; Stewart AJ; Yuen KY; Hinrichsen S; Dryburgh EL; Bertin FR
    J Vet Intern Med; 2020 May; 34(3):1350-1356. PubMed ID: 32255541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of sample handling and N-phenylmaleimide on concentration of adrenocorticotrophic hormone in equine plasma.
    Rendle DI; Litchfield E; Gough S; Cowling A; Hughes KJ
    Equine Vet J; 2015 Sep; 47(5):587-91. PubMed ID: 24980684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of basal plasma α-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses.
    Mc Gowan TW; Pinchbeck GP; Mc Gowan CM
    Equine Vet J; 2013 Jan; 45(1):66-73. PubMed ID: 22563728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circannual variability in adrenocorticotropic hormone responses to administration of thyrotropin-releasing hormone in clinically normal horses in Australia.
    Byrne DP; Secombe CJ; Tan RHH; Perera DI; Watts SP; Wearn JG
    Vet J; 2018 Aug; 238():58-62. PubMed ID: 30103916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses.
    Lee ZY; Zylstra R; Haritou SJ
    Vet J; 2010 Jul; 185(1):58-61. PubMed ID: 20537574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of breed differences in plasma adrenocorticotropic hormone concentrations among healthy horses and ponies.
    Bamford NJ; Stewart AJ; El-Hage CM; Bertin FR; Bailey SR
    Vet J; 2023; 296-297():105995. PubMed ID: 37207985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.
    Rendle DI; Duz M; Beech J; Parkin T; Durham AE
    J Vet Intern Med; 2015 Jan; 29(1):355-61. PubMed ID: 25312676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeatability of a thyrotropin-releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses.
    Kam YN; McKenzie K; Coyle M; Bertin FR
    J Vet Intern Med; 2021 Nov; 35(6):2885-2890. PubMed ID: 34642962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial analytic quality assessment and method comparison of an immunoassay for adrenocorticotropic hormone measurement in equine samples.
    Irvine KL; Burt K; Hill AJ; Shaw S; Papasouliotis K
    Vet Clin Pathol; 2016 Mar; 45(1):154-63. PubMed ID: 26756538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically and temporally specific diagnostic thresholds for plasma ACTH in the horse.
    Durham AE; Clarke BR; Potier JFN; Hammarstrand R; Malone GL
    Equine Vet J; 2021 Mar; 53(2):250-260. PubMed ID: 32470177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of equine pituitary pars intermedia dysfunction.
    Stewart AJ; Ireland JL; Durham AE; McGowan CM
    Vet J; 2023; 300-302():106036. PubMed ID: 37805159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of blue light therapy on plasma adrenocorticotropic hormone (ACTH) and hypertrichosis in horses with pituitary pars intermedia dysfunction.
    Miller AB; Murphy BA; Adams AA
    Domest Anim Endocrinol; 2022 Jan; 78():106651. PubMed ID: 34656964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circannual variation in plasma adrenocorticotropic hormone concentrations and dexamethasone suppression test results in Standardbred horses, Andalusian horses and mixed-breed ponies.
    Bamford NJ; Harris PA; Bailey SR
    Aust Vet J; 2020 Dec; 98(12):616-621. PubMed ID: 33001453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.